Kyverna’s CAR T Therapy Delivers ‘Impressive’ Mobility Benefits in Stiff Person Syndrome
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Kyverna's CAR T therapy has shown notable benefits in treating stiff person syndrome, with reports of impressive mobility improvements. The therapy's performance has been described as unprecedented, which may position Kyverna for a significant development in autoimmune CAR-T drugs. The results suggest a potentially major breakthrough in the treatment of stiff person syndrome.